1. Home
  2. XOS vs CLGN Comparison

XOS vs CLGN Comparison

Compare XOS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xos Inc.

XOS

Xos Inc.

HOLD

Current Price

$2.15

Market Cap

20.5M

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.46

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XOS
CLGN
Founded
2016
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
18.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOS
CLGN
Price
$2.15
$1.46
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$11.50
AVG Volume (30 Days)
43.2K
40.1K
Earning Date
11-13-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$52,246,000.00
$2,475,000.00
Revenue This Year
N/A
$1,596.12
Revenue Next Year
$25.72
$85.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
280.77
52 Week Low
$1.74
$1.30
52 Week High
$9.15
$4.98

Technical Indicators

Market Signals
Indicator
XOS
CLGN
Relative Strength Index (RSI) 51.81 37.10
Support Level $1.74 $1.37
Resistance Level $2.15 $1.51
Average True Range (ATR) 0.13 0.11
MACD 0.03 0.02
Stochastic Oscillator 89.04 53.78

Price Performance

Historical Comparison
XOS
CLGN

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: